tiprankstipranks
Trending News
More News >
Medpace Holdings (MEDP)
NASDAQ:MEDP
US Market
Advertisement

Medpace Holdings (MEDP) Earnings Dates, Call Summary & Reports

Compare
638 Followers

Earnings Data

Report Date
Feb 16, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
4.18
Last Year’s EPS
3.67
Same Quarter Last Year
Based on 10 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 22, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue and business growth, with significant net new business awards and a record net book-to-bill ratio. Despite these positive aspects, there were challenges related to a higher effective tax rate, lower interest income, and cancellations. Overall, the call demonstrates a strong performance with some areas for improvement.
Company Guidance
During Medpace's third-quarter 2025 earnings call, the company provided a preliminary view of its 2026 financial outlook. The guidance anticipates 2026 revenue to grow in a low double-digit range based on the updated 2025 full-year guidance. EBITDA is expected to increase at a high single-digit pace or greater. The company projects that pass-through costs will remain elevated compared to historical levels, representing between 41% and 42% of revenue. For the third quarter of 2025, Medpace reported revenue of $659.9 million, a 23.7% increase year-over-year, and an EBITDA of $148.4 million, up 24.9% from the previous year. The net book-to-bill ratio was 1.20, with net new business awards entering the backlog up 47.9% year-over-year to $789.6 million. Ending backlog was approximately $3 billion, with expectations that $1.84 billion of this will convert to revenue over the next 12 months. The company also updated its 2025 guidance, expecting total revenue to range from $2.48 billion to $2.53 billion, reflecting a growth of 17.6% to 20% over 2024, with an EBITDA range of $545 million to $555 million.
Record Net Bookings and Strong Net Book-to-Bill Ratio
Cancellations were well behaved in Q3, permitting record net bookings and a net book-to-bill of 1.20.
Significant Increase in Revenue
Revenue in the third quarter of 2025 was $659.9 million, representing a year-over-year increase of 23.7%.
Strong Growth in Net New Business Awards
Net new business awards entering backlog in the third quarter increased 47.9% from the prior year to $789.6 million.
EBITDA Growth
EBITDA of $148.4 million increased 24.9% compared to $118.8 million in the third quarter of 2024.
Cash Flow and Share Repurchase
Generated $246.2 million in cash flow from operating activities and repurchased approximately 14,649 shares for $4.5 million.

Medpace Holdings (MEDP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

MEDP Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 16, 2026
2025 (Q4)
4.18 / -
3.67
Oct 22, 2025
2025 (Q3)
3.54 / 3.86
3.0128.24% (+0.85)
Jul 21, 2025
2025 (Q2)
2.98 / 3.10
2.7512.73% (+0.35)
Apr 21, 2025
2025 (Q1)
3.06 / 3.67
3.214.69% (+0.47)
Feb 10, 2025
2024 (Q4)
2.94 / 3.67
2.4649.19% (+1.21)
Oct 21, 2024
2024 (Q3)
2.77 / 3.01
2.2235.59% (+0.79)
Jul 22, 2024
2024 (Q2)
2.54 / 2.75
1.9342.49% (+0.82)
Apr 22, 2024
2024 (Q1)
2.47 / 3.20
2.2740.97% (+0.93)
Feb 12, 2024
2023 (Q4)
2.22 / 2.46
2.1216.04% (+0.34)
Oct 23, 2023
2023 (Q3)
2.05 / 2.22
2.058.29% (+0.17)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

MEDP Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 22, 2025
$546.74$596.61+9.12%
Jul 21, 2025
$308.88$477.73+54.67%
Apr 21, 2025
$288.99$282.28-2.32%
Feb 10, 2025
$354.51$327.86-7.52%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Medpace Holdings (MEDP) report earnings?
Medpace Holdings (MEDP) is schdueled to report earning on Feb 16, 2026, After Close (Confirmed).
    What is Medpace Holdings (MEDP) earnings time?
    Medpace Holdings (MEDP) earnings time is at Feb 16, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is MEDP EPS forecast?
          MEDP EPS forecast for the fiscal quarter 2025 (Q4) is 4.18.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis